Integrated Care Pathway in Oncology (PASSION)

Assistance Publique - Hôpitaux de Paris

Status: Unknown

Conditions: Breast Cancer; Bladder Cancer; Thoracic Neoplasms; Gastric Cancer; Colon Cancer; Ovarian Cancer; Prostate Cancer; Pancreatic Cancer

Treatments: Behavioral: Care pathway unit

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04235556

APHP190973

Details and patient eligibility

About

A centralized unit for integrated management of care pathway in Oncology has been created. This unit settles the patients' appointments (biopsy, intravenous device, chemotherapy, imaging, oncologist...).

The aim of this study is to assess the delay between the first appointment with the oncologist and the beginning of the antitumoral treatment, and therefore evaluate the efficacy of the care pathway unit.

The second aim is to assess the satisfaction of patients and health care teams.

Full description

PASSION is a french monocentric study.

For the retrospective cohort, patient will be selected through the use of data warehouse available on the HEGP.

For the prospective cohort, patient will be included according to the selection criteria.

Each patient will be followed up during 6 month and a satisfaction questionnaire will be completed at 1 month and 4 month of the first administration of anti-tumor therapy.

For both cohort, clinical-anatomo-biological data will be collected through the use of data warehouse available on the HEGP.

Enrollment: 1,800 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histologically proven : colon, gastric, pancreatic, prostate, bladder, breast, thoracic, or ovarian cancer
• First appointment for cancer care at the Hôpital Européen Georges Pompidou
• Intravenous antitumoral treatment

Exclusion criteria

• Medical care non covered by social welfare
• Radiochemotherapy
• Death in the 6 months following first oncological appointment or absence of medical care in the year following the first oncological appointment

Trial design

1,800 participants in 2 patient groups

Historic cohort

Description:

Retrospective cohort of patients that were treated in the Hôpital Européen Georges Pompidou before the creation of the care pathway unit.

Prospective cohort

Description:

All consecutive patients that meet the inclusion criterion and will begin a cancer care after the study start.

Treatment:

Behavioral: Care pathway unit